Precision Biosciences (DTIL) Interest & Investment Income (2018 - 2026)
Precision Biosciences (DTIL) reported Interest & Investment Income of $999000.0 for Q1 2026, down 24.49% year-over-year from $1.3 million in Q1 2025, and up 29.24% on a QoQ basis from $773000.0 in Q4 2025.
Precision Biosciences (DTIL) has 9 years of Interest & Investment Income data on file, last reported at $999000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 24.49% year-over-year to $999000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (down 39.05% YoY) and the FY2025 annual result came in at $4.2 million, down 37.32% from the prior year.
- Interest & Investment Income grew to $999000.0 in Q1 2026 per DTIL's latest filing, from $773000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.0 million in Q1 2023 and bottomed at $172000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $1.5 million (2024), against an average of $1.4 million.
- The widest annual swing landed in 2022, when Interest & Investment Income surged 2974.6%; it then sank 48.26% in 2025.
- Tracing DTIL's Interest & Investment Income over 5 years: stood at $1.9 million in 2022, then dropped by 5.68% to $1.8 million in 2023, then declined by 18.23% to $1.5 million in 2024, then slumped by 48.26% to $773000.0 in 2025, then climbed by 29.24% to $999000.0 in 2026.
- Per Business Quant, the three latest DTIL Interest & Investment Income figures stand at $999000.0 (Q1 2026), $773000.0 (Q4 2025), and $1.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | 999,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 999,000.00 |
| Dec 31, 2025 | 773,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.66 Mn |
| Dec 31, 2023 | 1.83 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 1.95 Mn |
| Mar 31, 2023 | 2.04 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 192,000.00 |
| Mar 31, 2022 | 172,000.00 |
| Dec 31, 2021 | 63,000.00 |
| Sep 30, 2021 | 44,000.00 |
| Jun 30, 2021 | 48,000.00 |
| Mar 31, 2021 | 53,000.00 |
| Dec 31, 2020 | 27,000.00 |
| Sep 30, 2020 | 28,000.00 |
| Jun 30, 2020 | 107,000.00 |
| Mar 31, 2020 | 660,000.00 |
| Dec 31, 2019 | 945,000.00 |
| Sep 30, 2019 | 1.24 Mn |
| Jun 30, 2019 | 1.49 Mn |
| Mar 31, 2019 | 601,000.00 |
| Dec 31, 2018 | 662,000.00 |
| Sep 30, 2018 | 691,000.00 |
| Jun 30, 2018 | 299,000.00 |
| Mar 31, 2018 | 223,000.00 |